Delphi Projects

One of the HARMONY aims is to increase consistency in future clinical trials, allowing for the results to be compared and combined.

To do this, clinical trials need to use consistent core outcomes. Therefore, HARMONY researchers are running several Delphi Surveys to compile Core Outcome Sets (COS) for specific blood cancers/Hematologic Malignancies. 

The HARMONY Alliance Delphi Survey Hackathon for Chronic Myeloid Leukemia (CML), Hodgkin’s Lymphoma (HL), Myeloproliferative Neoplasms (MPN) and Waldenström Macroglobulinaemia (WM) took place on 4 and 18 March 2022. Patients, clinicians, regulators and drug developers were invited to participate. The Delphi Surveys for CML, HL, MPN and WM are now closed. Consensus meetings will take place in May 2022.

The ALL, AML, CLL, NHL, MDS and MM Delphi Surveys are completed.

What are COS and why do we need help from patients, clinicians, regulators and drug developers?